Cheil Bio Co., Limited. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cheil Bio Co., Limited. with three other
companies in this sector in South Korea:
Pharmicell Company Limited
sales of 25.20 billion Korean Won [US$23.41 million]
of which 87%
WooGene B&G CO., LTD
(26.43 billion Korean Won [US$24.56 million]
Daesung Microbiological Labs. Co., Limited
(24.04 billion Korean Won [US$22.34 million]
Cheil Bio Co., Limited. reported sales of 27.99 billion Korean Won (US$26.00 million)
December of 2017.
decrease of 21.9%
versus 2016, when the company's sales were 35.82 billion Korean Won.